Target intelligence / Profile preview

Interferon regulatory factor 2 binding protein 1 (IRF2BP1)

Target
IRF2BP1
Molecular classification
Transcriptional corepressor, Probable E3 ubiquitin-protein ligase (RING-type), Other (transcription regulator, cofactor)
01

Overview

Interferon regulatory factor 2 binding protein 1 (IRF2BP1) is a transcriptional corepressor and probable RING-type E3 ubiquitin-protein ligase. It interacts with transcription factors such as IRF2 via a conserved N-terminal zinc finger and a C-terminal RING domain. IRF2BP1 suppresses gene expression, notably in immediate early response genes such as DUSP1 and ATF3 upon EGF receptor signaling, by a SUMOylation-dependent mechanism. Its loss leads to increased cell proliferation and migration, linking IRF2BP1 to negative regulation of EGF receptor signaling and cell growth. The gene has been implicated in neurodevelopmental disorders and may play a regulatory role, along with related family members, in cancer and inflammation settings. No direct drug interactions or established uses as a clinical biomarker are currently reported[1][3][4].

Other names
IRF2BP1IRF-2-binding protein 1Interferon regulatory factor 2-binding protein 1IRF-2BP1DKFZP434M154Probable E3 ubiquitin-protein ligase IRF2BP1Probable RING-type E3 ubiquitin transferase IRF2BP1EC 2.3.2.27
02

Biological functions

Negative regulation of transcription by RNA polymerase IITranscriptional repression (not via histone deacetylase)Protein polyubiquitinationNegative regulation of EGF receptor signalingRegulation of gene expression, proliferation, and cell adhesion
03

Disease associations

Neurodevelopmental disorderCancer (regulation roles, not a primary oncogene or tumor suppressor)Potential roles in inflammation (related family members, limited evidence for IRF2BP1 itself)
04

Safety considerations

Potential impact on cell proliferation and migration if repressed or dysregulated (not directly identified as a clinical safety concern, but could influence oncogenesis through EGFR pathway modulation)

Beyond the preview

Go deeper on Interferon regulatory factor 2 binding protein 1 (IRF2BP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon regulatory factor 2 binding protein 1 (IRF2BP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call